Associação de fatores biológicos, determinantes sociais de saúde e hospitalização com a mortalidade devido a SRAG/COVID-19
DOI:
https://doi.org/10.17058/reci.v14i4.19438Palavras-chave:
Síndrome respiratória aguda grave, Registros de mortalidade, Vacinas contra COVID-19, Comorbidade, Teste para COVID-19Resumo
Justificativa e Objetivos: Investigar os fatores relacionados com a mortalidade em pacientes com síndrome respiratória aguda grave (SRAG), a fim de compreender as dinâmicas de transmissão, oferta de serviços de saúde e o perfil epidemiológico dos pacientes mediante a diversidade populacional, econômica e de assistência em saúde encontradas no Brasil. O presente estudo busca avaliar a associação de variáveis sociodemográficas, clínicas e de hospitalização em pacientes com por COVID-19 com a mortalidade entre a 14ª e 39 ª semana epidemiológica de 2021 em Ituiutaba-MG. Métodos: Estudo transversal com consulta local de notificações de SRAG, de diagnóstico e certidão de óbito. Razões de prevalência foram estimadas por regressão de Poisson. Resultados: Dos 8.770 casos confirmados, 592 notificações foram avaliadas entre 4 de abril a 2 de outubro de 2021. Poucos anos de estudo, vacinados com duas doses e necessidade de ventilação invasiva foram associadas ao óbito. O risco de morte aumentou a cada ano de vida (RP=1,03; IC95% 1,02-1,04), na presença de doença crônica (RP=1,55; IC95% 1,1-2,18), e para os hospitalizados na UTI (RP= 3,49 IC95% 2,7-4,54). Conclusão: Além da idade, as condições clínicas preexistentes e a internação em UTI são contributivas para o óbito.
Downloads
Referências
Machhi J, Herskovitz J, Senan AM, et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol 2020; 15: 359-86. https://doi.org/10.1007%2Fs11481-020-09944-5.
Burki T. COVID-19 in Latin America. Lancet Infect Dis 2020; 20(5):547-548. https://doi.org/10.1016/s1473-3099(20)30303-0.
Brasil. Ministério da Saúde. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil. [citado 2024 Jan 29]. Disponível em: https://covid.saude.gov.br/.
Brasil. Ministério da Saúde. Ministério da Saúde - Cobertura vacinal - COVID-19. [citado 2024 Jan 29]. Disponível em: https://infoms.saude.gov.br/extensions/SEIDIGI_DEMAS_COBERTURA_COVID_OCORRENCIA/SEIDIGI_DEMAS_COBERTURA_COVID_OCORRENCIA.html.
Santos CVB dos, Noronha TG de, Werneck GL, et al. Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: a retrospective observational study. Lancet Reg Health Am 2023; 17:100418. https://doi.org/10.1016/j.lana.2022.100418.
Brasil. Ministério da Saúde. Estratégia de vacinação contra a COVID-19 - 2024. 1. ed. Brasília: Ministério da Saúde; 2023. 61p. Disponível em: https://infoms.saude.gov.br/content/Default/Informe%20vacinacao%20covid%202024_final_29dez23.pdf.
Zhang JJ, Dong X, Liu GH, et al. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin Rev Allergy Immunol 2023; 64(1): 90-107. https://doi.org/10.1007/s12016-022-08921-5.
Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: Retrospective cohort study. BMJ 2021; 372: n693. https://doi.org/10.1136/bmj.n693.
Li J, Zhou Y, Ma J, et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther 2023; 8(1): 416. https://doi.org/10.1038/s41392-023-01640-z
Fernandes AT, Rodrigues EK, Araújo ER, et al. Risk factors and survival in patients with COVID-19 in northeastern Brazil. PLoS One 2022; 17(11): e0278213. https://doi.org/10.1371/journal.pone.0278213.
Wang Y, Dong C, Han Y, et al. Immunosenescence, aging and successful aging. Front Immunol 2022; 13: 942796. https://doi.org/10.3389/fimmu.2022.942796.
Zeiser FA, Donida B, André da Costa C, et al. First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality. Lancet Reg Health Am 2022; 6: 100107. https://doi.org/10.1016/j.lana.2021.100107.
Colnago M, Benvenuto GA, Casaca W, et al. Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil. Bioengineering 2022; 9(10): 584. https://doi.org/10.3390/bioengineering9100584.
Moura EC, Cortez-Escalante J, Cavalcante FV, et al. Covid-19: temporal evolution and immunization in the three epidemiological waves, Brazil, 2020-2022. Rev Saúde Pública 2022; 56: 105. https://doi.org/10.11606/s1518-8787.2022056004907.
Kerr S, Bedston S, Cezard G, et al. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales. Lancet 2024; 403: 554-566. https://doi.org/10.1016/S0140-6736(23)02467-4.
Dananché C, Elias C, Hénaff L, et al. Baseline clinical features of COVID-19 patients, delay of hospital admission and clinical outcome: A complex relationship. PLoS One. PLoS One 2022; 17(1): e0261428. https://doi.org/10.1371/journal.pone.0261428.
Thakur B, Dubey P, Benitez J, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep 2021; 11: 8592. https://doi.org/10.1038/s41598-021-88130-w.
Kowsar R, Rahimi AM, Sroka M, et al. Risk of mortality in COVID-19 patients: a meta- and network analysis. Sci Rep 2023; 13(1): 2138. https://doi.org/10.1038/s41598-023-29364-8.
Schutte AE, Srinivasapura Venkateshmurthy N, Mohan S, et al. Hypertension in Low- and Middle-Income Countries. Circ Res 2021; 128(7): 808-826. https://doi.org/10.1161/circresaha.120.318729.
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: A systematic review and meta-analysis of observational studies. BMJ Open 2021; 11(10): e052777. https://doi.org/10.1136/bmjopen-2021-052777.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021; 21(1): 855. https://doi.org/10.1186/s12879-021-06536-3.
Alaa A, Qian Z, Rashbass J, et al. Retrospective cohort study of admission timing and mortality following COVID-19 infection in England. BMJ Open 2020; 10(11): e042712. https://doi.org/10.1136/bmjopen-2020-042712.
Scohy A, Anantharajah A, Bodéus M, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020; 129: 104455. https://doi.org/10.1016/j.jcv.2020.104455.
Lima FET, de Albuquerque NLS, Florencio SSG, et al. Time interval between onset of symptoms and COVID-19 testing in Brazilian state capitals, 2020. Epidemiol Serv Saude 2021; 30(1): e2020788. https://doi.org/10.1590/S1679-4974202100010002.
Funk T, Pharris A, Spiteri G, et al. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Euro Surveill 2021; 26(16): 2100348. https://doi.org/10.2807/1560-7917.es.2021.26.16.2100348.
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Victor Antonio Ferreira Freire, Gustavo Siconello dos Santos, Morun Bernardino Neto, Luciana Calábria, Alexandre Azenha Alves de Rezende
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
